Upstream Bio (UPB) Receivables: 2023-2025
Historic Receivables for Upstream Bio (UPB) over the last 1 years, with Sep 2025 value amounting to $2.3 million.
- Upstream Bio's Receivables rose 111.26% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2024, which is 400.00% up from last year.
- Latest data reveals that Upstream Bio reported Receivables of $2.3 million as of Q3 2025, which was down 12.75% from $2.6 million recorded in Q2 2025.
- Upstream Bio's 5-year Receivables high stood at $2.6 million for Q2 2025, and its period low was $236,000 during Q4 2023.
- Over the past 3 years, Upstream Bio's median Receivables value was $1.2 million (recorded in 2024), while the average stood at $1.4 million.
- Data for Upstream Bio's Receivables shows a peak YoY spiked of 400.00% (in 2024) over the last 5 years.
- Over the past 3 years, Upstream Bio's Receivables (Quarterly) stood at $236,000 in 2023, then surged by 400.00% to $1.2 million in 2024, then spiked by 111.26% to $2.3 million in 2025.
- Its Receivables stands at $2.3 million for Q3 2025, versus $2.6 million for Q2 2025 and $1.7 million for Q1 2025.